Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

NCT02590263 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
Glioblastoma Multiforme

Interventions

RADIATION: Whole Brain Radiation
DRUG: Temozolomide
DRUG: ABT-414

Sponsor

AbbVie